Enzolytics Inc (ENZC)

[foxi]

Took a look at the disclosure statement, seems to be in order with no big surprises.

https://www.otcmarkets.com/otcapi/company/financial-report/351987/content


- Disclosure is correctly listing common shares outstanding, this time.

- 2.5 Mil Series E sold May 19, 2022 to raise cash.

- Extra line of clarification added on Page 6 "As a result of the merger termination, IMMB is a wholly separate entity from Enzolytics, Inc."

- Company physical address changed in August on Page 9: "On August 15, 2022, the company signed a lease its new physical address and telephone number, 1101 Raintree Circle, Suite 130 Allen, Texas 75013, telephone number, [phone]."

- Clarified on Page 9 that it was "through Bioclonetics" that the company leased office and lab space from Texas A & M University in December 2020.

- Clarified on Page 9 regarding Malone Bailey: "There were no unresolved accounting or financial issues between the parties." speaking in past tense this time, so it would seem the reason for terminating MB was not because of ENZC's accounting.

- The description on IPF Immune on Page 12 went from "Tested Immune Modulator" in the prior filing to "a dietary liquid supplement" in this filing. The language has been watered down to say "IPF Immune could be used as an immune supporter." Phrases like "immune modulator", "fortifying [the immune system] against infections", and "supporting the body's antioxidant defense" are gone from this filing. These changes are echoed in the verbiage on Page 15.

- There is no further info no what is the status of IPF Immune. It's "Introduced into the U.S. Market" per Page 13, but no one can buy it and shops are not selling it.

- There is no further info on Africa on Page 13, all we have is the same info as the prior filing.

- Recap of Abveris relationship on Page 14 but no new info.

- The ITV-1 toxicology study is noted on Page 14. The company says it "continues to progress with the GLP Compliant 28-day Repeat Dose Toxicity Study."

- Changes in company Facilities on Page 15 compared to the last filing. Company looks to be moving offices and labs from Plano to Allen TX. (Those cities are neighbors.)

- A couple new Company Insiders on Page 16 but no changes to numbers in the table.

- Investor Relations is blank on Page 17. (Tom is now gone.)